W Korytowski

Plain English
This study looked at how light and dark conditions affect photooxidative damage in cells, which is important for cancer treatments like photodynamic therapy (PDT). Researchers found that different sequences of light and dark exposure can produce harmful reactive molecules that can either harm or help cell treatment, depending on how they are managed. Understanding these processes can improve the effectiveness of PDT and lead to better treatment outcomes for patients. Who this helps: This helps cancer patients undergoing photodynamic therapy.

Plain English
Researchers studied how a damaged form of cholesterol called 7-OOH moves into the mitochondria (the cell's power plants) of testosterone-producing cells in the testis, and they found it causes dangerous chemical damage that blocks testosterone production. They discovered that an enzyme called GPx4 normally protects these cells from this damage, but when they disabled GPx4, the cells became much more vulnerable to the toxic effects of 7-OOH. This matters because it reveals a previously unknown protective mechanism in testis cells and could help explain how oxidative stress damages male fertility.

Plain English
Researchers studied what happens to cancer cells that survive a type of light-based cancer treatment called photodynamic therapy (PDT). They found that surviving cancer cells produce a chemical called nitric oxide that makes them tougher, more mobile, and more likely to spread to other parts of the body—essentially making the remaining cancer more aggressive and harder to kill. The nitric oxide from these surviving cells also spreads to nearby cancer cells that weren't directly treated, making those cells dangerous too. This means PDT's benefits could be undermined unless doctors use additional drugs to block this chemical and prevent the surviving cancer cells from becoming more aggressive.

Plain English
Researchers studied how damaged fat molecules (created when cell membranes break down under stress) move around inside cells and cause harm—specifically, how proteins that normally manage cholesterol movement can accidentally transport these damaged fats into mitochondria (the cell's power plants), making the damage worse. They found that a protective enzyme called GPx4 can stop this harmful transport and prevent the damage from spreading. This matters because this process is linked to heart disease, brain degeneration, and cancer, so understanding how to block it could lead to new treatments.

Plain English
Researchers studied what happens when a cancer treatment called photodynamic therapy (PDT) partially kills cancer cells—they found that surviving cancer cells produce a chemical called nitric oxide that makes nearby untreated cancer cells grow faster and spread more aggressively. This is a problem because it means the treatment could accidentally help the tumor recover and become more dangerous, even though it killed some cancer cells. The researchers suggest that doctors could improve this therapy by adding drugs that block nitric oxide production, preventing the surviving cancer cells from helping their neighbors grow.

Plain English
Researchers studied what happens when cancer cells are treated with a light-based therapy called photodynamic therapy (PDT): the treated cells release a chemical called nitric oxide that spreads to nearby untreated cancer cells, causing those bystander cells to grow and spread faster instead of dying. They found that the amount of this bystander effect depends on how much nitric oxide the treated cells produce, and they could recreate the same effect by adding nitric oxide directly to untreated cells. This matters because it reveals a major problem with PDT—the therapy might accidentally make some cancer cells more aggressive—but the good news is that blocking nitric oxide with existing drugs could potentially prevent this harmful side effect.

Plain English
Researchers studied what happens to harmful fat molecules (lipid hydroperoxides) created when cancer cells are treated with light-based therapy—these molecules can either break down harmlessly, trigger dangerous chain reactions that damage cells, or move to other parts of the cell where they cause more damage. The key finding was that these harmful molecules can travel between different cellular membranes, spreading the damage beyond where they were originally created. This matters because it shows that light-based cancer treatment creates more widespread cellular damage than previously understood, which could explain both why the therapy works and what side effects it causes.

Plain English
Researchers exposed male reproductive cells to cholesterol mixed with a damaged version of cholesterol (created by oxidative stress), and found that this damaged form gets transported into the cells' mitochondria where it causes harmful chemical reactions that prevent the cells from making the hormone progesterone and eventually kills the cells. The cells have a natural defense enzyme called GPx4 that can neutralize this damage, and when researchers blocked this enzyme, the harm got worse—but when they added a substance that mimicked this enzyme's protective function, the cells recovered.

Plain English
Researchers studied how a molecule called nitric oxide helps cancer cells survive chemotherapy, radiation, and other cancer treatments—and makes those surviving cells even more aggressive and dangerous. They found that cancer cells that manage to survive these treatments produce extra nitric oxide, which makes them spread faster and invade surrounding tissue more readily, and this aggressive behavior can even spread to nearby cancer cells that weren't directly hit by the treatment. This matters because it explains why some cancers come back stronger after treatment, and the researchers suggest that blocking nitric oxide production could be added to cancer therapies to prevent this dangerous rebound effect.

Plain English
Researchers reviewed how damaged cholesterol and fats in cell membranes can move between different parts of cells during oxidative stress (when cells are exposed to harmful reactive molecules), potentially causing heart disease, brain degeneration, and cancer. They discovered that a protein normally responsible for transporting cholesterol actually also transports damaged cholesterol to the wrong locations in cells, where it interferes with important processes like hormone production and cholesterol removal from blood vessels. The findings suggest that antioxidant treatments might prevent this harmful transport and reduce disease risk.

Plain English
Researchers studied how a cancer treatment called photodynamic therapy (PDT) kills tumor cells by creating damaging molecules called free radicals that attack cell membranes, and they discovered that cancer cells can protect themselves by producing nitric oxide—a natural chemical that stops these damaging reactions. The team found that when they added nitric oxide to their experiments, it blocked the chain reaction of damage to cell membranes by interceding with the harmful free radicals, acting like a safety mechanism that prevented the therapy from working effectively. This matters because it reveals why some aggressive cancers are resistant to photodynamic therapy: cancer cells are actively producing nitric oxide to defend themselves, so blocking this defense mechanism could make the treatment much more effective.

Plain English
Researchers studied glioblastoma (an aggressive brain cancer) treated with photodynamic therapy—a technique that uses light to activate a drug that kills cancer cells. They discovered that when this light treatment stressed the cancer cells, the cells produced a molecule called nitric oxide that actually protected them from dying and made the surviving cells spread more aggressively. This matters because it explains why photodynamic therapy sometimes fails against this cancer, and it suggests that combining this light treatment with drugs that block nitric oxide production could make the therapy much more effective.

Plain English
Researchers studied why a promising light-based cancer treatment (photodynamic therapy) fails against aggressive brain tumors called glioblastomas—specifically, they found that tumor cells produce a chemical called nitric oxide that helps them survive the treatment and grow back even more aggressively afterward. The team identified the exact chain of events inside the cancer cells that triggers this protective nitric oxide production when exposed to the light therapy. They discovered that a drug called JQ1 can block this protective mechanism, which means combining JQ1 with the light treatment should make the therapy much more effective at killing glioblastoma cells.

Plain English
Researchers studied what happens when cholesterol in your body is damaged by light and oxygen—a process that creates harmful compounds called cholesterol hydroperoxides. These damaged cholesterol molecules can damage cell membranes and trigger chemical reactions inside cells that may harm health, but they can also send signals that affect whether cells live or die. The findings matter because cholesterol damage from light and oxygen happens naturally in the body and may contribute to diseases, yet scientists still don't fully understand how these damaged molecules communicate with cells to cause harm—knowledge that could eventually lead to new treatments.

Plain English
Researchers studied how brain tumors called glioblastomas survive a light-based cancer treatment called photodynamic therapy by producing a chemical called nitric oxide that protects them and makes them more aggressive. They found that this protective response depends on a chain of molecular events: the treatment damages a tumor-suppressor protein called PTEN, which then triggers a domino effect of activations that turns on the gene for nitric oxide production, while simultaneously shutting down a protective protein that would normally prevent this. Blocking nitric oxide production or stopping the chain reaction at various points makes the treatment work much better, suggesting these molecular targets could be combined with photodynamic therapy to overcome the tumor's resistance.

Plain English
Researchers treated cancer cells with a light-based therapy called photodynamic therapy and found that surviving treated cells released a chemical called nitric oxide, which then encouraged nearby untreated cancer cells to grow and spread faster. The effect was stronger in some cancer types (prostate and breast) than others (brain and skin). This matters because if this happens in actual tumors, it could undermine the therapy's effectiveness or even make cancer worse—unless doctors find ways to block this chemical signal.

Plain English
Researchers exposed cancer cells to a light-based treatment and found that untreated cancer cells nearby became more aggressive and grew faster, even though they never touched the treated cells—this happened because the treated cells released a chemical messenger called nitric oxide that triggered growth signals in the bystander cells. Blocking nitric oxide with drugs stopped the bystander cells from becoming more aggressive, suggesting that doctors could potentially use nitric oxide-blocking drugs alongside this light therapy to prevent cancer cells from becoming more dangerous. This discovery is important because previous cancer treatments were known to have similar unwanted side effects on nearby untreated cells, but nobody had documented this specific problem with light-based therapy before.

Plain English
Cholesterol in your cell membranes and in the fatty particles that carry cholesterol through your blood gets damaged when your body is under oxidative stress—essentially when harmful molecules called free radicals attack it. This damage creates unstable cholesterol molecules called hydroperoxides that can spread to other parts of your cells or between different fat particles, amplifying the harm and contributing to diseases like heart disease and a newly discovered form of cell death called ferroptosis.

Plain English
Researchers discovered that when cancer cells are treated with a light-based therapy called photodynamic therapy, nearby untreated cancer cells actually start growing faster and spreading more, even though they were never directly exposed to the treatment. The treated cells release a chemical called nitric oxide that triggers this dangerous response in neighboring cells, creating a self-reinforcing cycle that makes the cancer more aggressive. The study suggests that blocking nitric oxide with drugs could prevent this unwanted side effect and improve how well this cancer treatment works.

Plain English
Researchers developed a new way to measure how much damage free radicals cause to fats in cells and blood by tracking what happens to cholesterol when it gets attacked. They used radioactively labeled cholesterol and a special detection method to identify the specific damaged cholesterol products that form over time in various biological systems like cell membranes and blood lipoproteins. This matters because it's a more accurate way to assess cellular damage from free radicals without using artificial measurement tools that can skew results—giving doctors and scientists a clearer picture of oxidative stress in living systems.

Plain English
Researchers tested a new light-based cancer treatment called photodynamic therapy on aggressive brain tumor cells and discovered that the tumor cells produce a protective chemical called nitric oxide that actually helps them survive the treatment. When they blocked this protective chemical with drugs, the cancer cells died more effectively and were less likely to spread. The study shows that adding nitric oxide-blocking drugs to photodynamic therapy could make this treatment much more effective against brain tumors.

Plain English
Researchers studied how a cancer treatment called photodynamic therapy works and discovered that cancer cells fight back against it by producing a molecule called nitric oxide, which blocks the treatment's effectiveness and makes surviving cancer cells more aggressive and likely to spread. The study found this happens in multiple ways: nitric oxide helps cancer cells resist death from the treatment, makes remaining cancer cells grow and move faster, and can even trigger nearby untargeted cancer cells to become more aggressive too. The research suggests that combining this cancer treatment with drugs that block nitric oxide production could prevent these harmful side effects and make the therapy more effective.

Plain English
Researchers studied how oxidative stress (cellular damage from harmful molecules) affects the ability of immune cells called macrophages to remove cholesterol from artery walls—a process that normally protects against heart disease. They discovered that a specific toxic form of oxidized cholesterol (7-OOH) gets transported into the cell's power plants (mitochondria) and damages them, which then shuts down the cholesterol removal system. This matters because people with conditions like obesity and high blood pressure have high oxidative stress, and this research explains a new reason why their bodies can't clear cholesterol from arteries effectively, leading to heart disease.

Plain English
Researchers studied how cells remove excess cholesterol from arteries—a process that helps prevent heart disease—and found that under stressful conditions, a protein called StarD1 accidentally transports harmful oxidized cholesterol into the cell's power plants (mitochondria) instead of just regular cholesterol. This damaged the mitochondria and shut down the cholesterol removal process, essentially jamming up the system that's supposed to protect us from heart disease. This discovery matters because it explains why people under chronic stress or with inflammatory diseases have worse cholesterol control and higher heart disease risk.

Plain English
Researchers found that when cells that make sex hormones are stimulated, they produce proteins that actively transport damaged cholesterol (cholesterol with extra oxygen attached) into the cell's power plants (mitochondria), where it causes destructive free radical damage instead of being used to make hormones. When these hormone-making cells were exposed to this damaged cholesterol, the stimulated cells took in much more of it, their mitochondria lost the ability to function, and the cells died—but knocking down the transport protein stopped this damage from happening. This matters because it explains how oxidative stress (an imbalance of damaging molecules in cells) can break down the body's ability to produce hormones like testosterone and progesterone, which could help explain hormone problems related to aging, infertility, or metabolic disease.

Plain English
This study looked at how certain proteins, Bax and tBid, interact with oxidized forms of a fat called cardiolipin to affect cell death processes. Researchers discovered that oxidized cardiolipin helps these proteins create openings in the mitochondrial membrane, facilitating the release of a protein called cytochrome c, which is a key step in cell death. They found that oxidized cardiolipin made it easier for these proteins to work together and trigger this release, which could have significant implications for understanding diseases involving excessive cell death, like heart disease or certain cancers. Who this helps: This research benefits patients with conditions related to cell death, such as heart disease and cancer, by providing insights into potential therapeutic targets.

Plain English
This study looked at how a protein called StarD4 affects the movement of a type of damaged cholesterol (7-hydroperoxycholesterol) into mitochondria, the energy-producing parts of cells. Researchers discovered that StarD4 speeds up the transfer of this harmful cholesterol into liver mitochondria, leading to increased cell damage from free radicals. This is important because when cells are under stress, the faulty handling of this damaged cholesterol could harm their ability to produce essential hormones. Who this helps: This helps doctors and researchers understand the risks associated with oxidative stress in patients, particularly in hormone-producing tissues.

Plain English
This study looked at how nitric oxide (NO) affects tumor cells during a specific cancer treatment called photodynamic therapy. Researchers found that when they used a substance (SPNO) that releases NO before exposing the cells to light, the cells started dying by apoptosis (a controlled cell death) instead of necrosis (a chaotic cell death). Specifically, cells treated with SPNO showed a big increase in a protein that indicates apoptosis, and this was especially effective when the tumor cells were low on glucose. Who this helps: This research benefits cancer patients undergoing photodynamic therapy by potentially improving the effectiveness of their treatment.

Plain English
This study examined how different forms of a cholesterol-related compound, 6-hydroperoxycholesterol, react in cell membranes. Researchers found that one type, 5alpha-OOH, caused significant damage to cells, while another type, 6beta-OOH, did not harm cells at all. This is important because it helps us understand how certain types of damage are linked to exposure to sunlight and could inform treatments for conditions affecting skin and eye health. Who this helps: Patients suffering from skin and eye conditions related to sun exposure.

Plain English
This study looked at how nitric oxide (NO) affects the ability of human breast tumor cells (COH-BR1) to resist damage from light-based treatments. The researchers found that exposing the cells to a specific dose of NO made them substantially more resistant to photodynamic therapy, improving their survival rate against photooxidative killing by about 20 hours after treatment. These findings are important because they suggest that nitric oxide could enhance the effectiveness of light-based cancer treatments, potentially improving outcomes for patients. Who this helps: This helps patients undergoing photodynamic therapy for breast cancer.

Plain English
This research studied how a protein called sterol carrier protein-2 (SCP-2) affects liver cancer cells when they are exposed to a type of cholesterol that can cause oxidative stress. The scientists found that liver cancer cells with more SCP-2 (called SC2A cells) absorbed this cholesterol much faster and were about four times more sensitive to its harmful effects compared to normal cells. This matters because it highlights how certain proteins can influence the damaging effects of oxidative stress, potentially leading to targeted therapies for liver cancer. Who this helps: Patients with liver cancer may benefit from understanding how their cells react to oxidative stress.

Plain English
This study investigated how a particular type of cancer treatment called photodynamic therapy (PDT) works at the cellular level. The researchers found that a substance produced during this therapy, called protoporphyrin IX, leads to damage in a part of the cell called the mitochondria, which is crucial for cell death. They discovered that a significant early event, indicated by a 70% slower accumulation of certain harmful compounds in treated cells, plays a key role in causing cancer cells to die. Who this helps: This research benefits cancer patients undergoing photodynamic therapy.

Plain English
This study looked at how nitric oxide (NO) can protect a compound called protoporphyrin IX (PpIX) from breaking down when exposed to light and certain chemicals. Researchers found that adding NO nearly completely stopped the breakdown of PpIX and the build-up of harmful substances in cell membranes, which normally happens when PpIX is activated by light. This is important because longer-lasting PpIX could improve treatments, like photodynamic therapy, used to kill cancer cells. Who this helps: This benefits patients undergoing photodynamic therapy for cancer.

Plain English
This study investigated how a dye called merocyanine 540 (MC540) can damage leukemia cells when exposed to light. The researchers found that this process involves damaging lipids in the cell membrane and that nitric oxide (NO) can protect the cells by reducing this damage. Specifically, they showed that when NO was present, it significantly prevented the buildup of harmful substances that contribute to cell death, helping to keep cells alive more effectively. Who this helps: This benefits leukemia patients by providing insights into new ways to protect their healthy cells during cancer treatments.

Plain English
Researchers developed a new method to separate and measure specific types of phospholipid hydroperoxides (PLOOHs), which are molecules that can be harmful when produced in excess in the body. They successfully identified and quantified four important classes of these molecules from stressed leukemia cells, achieving very precise measurements capable of detecting tiny amounts (as low as 0.1 to 0.5 picomoles). This new method is more sensitive and reliable than existing techniques, making it important for better understanding how these molecules behave in biological systems. Who this helps: This helps scientists and doctors studying cell damage and related diseases.

Plain English
This study focused on how a protein called sterol carrier protein-2 (SCP-2) helps move harmful fat molecules known as hydroperoxides between cell membranes. Researchers found that SCP-2 significantly speeds up the transfer of these hydroperoxides, with some types moving up to seven times faster than normal cholesterol. This is important because faster movement of these damaging molecules can increase cell injury, especially during conditions that cause oxidative stress, which can occur in various diseases. Who this helps: Patients with conditions related to oxidative stress, such as cardiovascular disease or neurodegenerative disorders.

Plain English
This study looked at the amount of melanin, a pigment that protects the eyes, in cells from the human retina at different ages. Researchers found that melanin levels decrease by about 2.5 times from early life to old age, and this loss may be linked to damage caused by light exposure. Understanding these changes is important because they could explain why older individuals may be more vulnerable to eye diseases. Who this helps: This helps patients, especially older adults at risk for eye problems.

Plain English
This study investigated how nitric oxide can protect cells from damage caused by free radicals during photodynamic therapy, a treatment that uses light to kill cancer cells. Researchers found that the nitric oxide donor, spermine-NONOate, did not reduce certain harmful lipid oxidation products when added before light exposure, but it effectively prevented more damaging secondary products from forming during the treatment. This finding is important because it suggests that using nitric oxide could help reduce the side effects of certain cancer therapies, making them safer and potentially more effective. Who this helps: This helps cancer patients undergoing photodynamic therapy.

Plain English
This study looked at how nitric oxide (NO) can protect tumor cells from being destroyed by a special light therapy that uses a compound from a common drug called 5-aminolevulinic acid (ALA). The researchers found that when they treated breast tumor cells with NO, it significantly reduced cell damage and improved cell survival. Specifically, the NO treatment prevented harmful effects caused by free radicals, but only when given before the light therapy, showing that timing is important for its protective effects. Who this helps: This helps cancer patients undergoing photodynamic therapy by potentially improving their treatment outcomes.

Plain English
This study looked at how two antioxidants, alpha-tocopherol and zeaxanthin, work together to protect against a type of chemical damage in cells caused by light exposure. The researchers found that while zeaxanthin alone could effectively protect cells at a low concentration of 2.5 microM, alpha-tocopherol alone didn't help at all. However, when combined, these two antioxidants worked better together, with alpha-tocopherol preventing zeaxanthin from being used up too quickly, allowing it to do its job of blocking damage caused by light. Who this helps: This benefits patients who are at risk for light-induced cell damage, such as those with certain skin conditions or eye disorders.

Plain English
This study looked at how aging affects the way retinal pigment epithelial (RPE) melanosomes react to blue light and compared these reactions to a substance called lipofuscin. Researchers found that older melanosomes took in more oxygen when exposed to blue light and produced more reactive compounds, but this was still less than the reaction seen with lipofuscin. This is important because the increased reactivity in aged melanosomes could lead to cellular damage and contribute to eye disorders. Who this helps: This helps patients with aging-related eye conditions.

Plain English
This study looked at how a treatment called photodynamic therapy (PDT) affects breast cancer cells when combined with a substance called 5-aminolevulinic acid (ALA). Researchers tested two methods of applying ALA and found that when ALA was present longer, it led to cell death through a process called apoptosis, while a shorter exposure caused necrosis. Additionally, cells with a specific enzyme called GPX4, which helps break down harmful substances, showed significantly reduced cell death when treated under the longer ALA exposure method, indicating that this enzyme plays a crucial protective role. Who this helps: This research benefits cancer patients by providing insights into how therapies can be optimized to improve treatment outcomes.

Plain English
This study looked at how certain harmful lipids (fatty substances) move from blood cells to low-density lipoprotein (LDL), which is often linked to heart disease. The researchers found that these lipids moved to LDL much more quickly than the original fat molecules, with some transfers happening roughly 60 times faster. This is important because when LDL takes on these lipids, it becomes more vulnerable to damage that can lead to artery problems. Who this helps: This helps patients at risk for heart disease by improving understanding of how LDL can become harmful.

Plain English
This study looked at how a specific enzyme, GPX4, helps breast tumor cells resist damage caused by harmful substances called cholesterol hydroperoxides. Researchers found that cells with higher levels of GPX4 were up to 190 times better at surviving this kind of damage compared to normal cells. This is important because it highlights a potential way for tumor cells to protect themselves from being killed by oxidative stress, which could help in developing treatments that target this protective mechanism. Who this helps: Patients with breast cancer.

Plain English
This study looked at how certain cholesterol-derived compounds, known as hydroperoxides, move between cell membranes and how quickly this happens. Researchers found that when about 4% of cholesterol in donor membranes was oxidized, the hydroperoxides transferred to other membranes at a rate 65 times faster than regular cholesterol transfer. This is important because these hydroperoxides can be harmful to cells, especially in those that struggle to break them down. Who this helps: This research benefits patients with conditions that involve oxidative stress, as well as doctors treating such conditions.

Plain English
This study looked at how nitric oxide (NO) can protect liposomal membranes from damage caused by free radicals, particularly in relation to cholesterol. Researchers found that adding NO to the reaction slowed down harmful changes in the lipids significantly, with a 50% reduction in TBARS and other oxidized cholesterol products when using NO donors. This is important because it helps to understand how to prevent cholesterol damage, which can be linked to various health issues. Who this helps: This helps patients at risk of heart disease or other cholesterol-related conditions.

Plain English
This study looked at how cholesterol-related compounds (lipid hydroperoxides) can move between cell membranes and potentially cause damage. Researchers found that when these compounds were transferred, they moved about 16 times faster than the normal cholesterol, which can lead to harmful chain reactions that damage cells. This is important because it highlights a way that cell membranes can be harmed by oxidative stress, which is linked to many diseases. Who this helps: This helps patients at risk of oxidative stress-related diseases, such as heart disease and neurodegenerative disorders.

Plain English
This study looked at how cholesterol can help detect a type of reactive oxygen called singlet oxygen in living cells. Researchers found that specific chemical changes in cholesterol occur when it reacts with singlet oxygen, which can be tracked using different testing methods. This discovery is important because it can improve our understanding of how cells respond to oxidative stress and could help in the development of treatments for various diseases linked to oxidative damage. Who this helps: This benefits researchers studying diseases caused by oxidative stress and developing new therapies.

Plain English
This study examined how different rates of nitric oxide release impact its ability to protect cellular membranes from damage caused by free radicals, which can lead to cholesterol oxidation. Researchers tested three nitric oxide donors that release the compound at different speeds and found that the slower-releasing types more effectively reduced the formation of harmful oxidation products: PANO decreased this formation by 45%, while SPNO was also effective, although to a lesser degree. Understanding how the release rate of nitric oxide can influence protection against cell damage is crucial for developing better treatments for conditions linked to oxidative stress. Who this helps: This helps patients at risk of oxidative stress-related diseases.

Plain English
This study looked at how different forms of oxidized cholesterol, created when cholesterol reacts with a form of oxygen during light exposure, can affect cells. The researchers found that one specific type of oxidized cholesterol, called 5 alpha-OOH, appears much faster and is more harmful to cells than other forms, like 6 alpha-OOH and 6 beta-OOH. This is important because it helps us understand how cholesterol can become harmful in cells exposed to light and might aid in developing better treatments for conditions related to cell damage. Who this helps: This helps patients with conditions related to oxidative stress and medical professionals seeking to develop safer treatments.